Taltz (ixekizumab) Disease Interactions
There are 4 disease interactions with Taltz (ixekizumab):
Ixekizumab (applies to Taltz) infections
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Infection - Bacterial/Fungal/Protozoal/Viral
Upper respiratory tract infections, oral candidiasis, conjunctivitis, and tinea infections have occurred with the use of ixekizumab. Close monitoring or discontinuation of therapy is recommended in patients with serious infections that do not respond to conventional treatment. It is recommended to restart therapy only until the infection resolves.
Ixekizumab (applies to Taltz) inflammatory bowel disease
Moderate Potential Hazard, Moderate plausibility.
Crohn's disease and ulcerative colitis, including exacerbations have occurred during ixekizumab treatment. Caution and close monitoring for onset or exacerbation of inflammatory bowel disease are recommended.
Ixekizumab (applies to Taltz) tuberculosis
Moderate Potential Hazard, Moderate plausibility. Applicable conditions: Tuberculosis -- Active, History - Tuberculosis, Tuberculosis -- Latent
Patients should be evaluated for tuberculosis (TB) infection prior to ixekizumab treatment. It is recommended to initiate treatment of latent TB prior to administering ixekizumab and to consider anti-TB therapy prior to initiating therapy in patients with a past history of latent or active TB in whom an adequate course of treatment cannot be confirmed. Do not administer this agent to patients with active TB infection. Patients should be monitored closely for signs and symptoms of active TB during and after treatment.
Ixekizumab (applies to Taltz) renal/hepatic impairment
Minor Potential Hazard, Moderate plausibility. Applicable conditions: Renal Dysfunction, Liver Disease
No formal clinical studies of the effect of hepatic or renal impairment on the pharmacokinetics of ixekizumab have been conducted. Care should be taken when prescribing this drug to these patients.
Taltz (ixekizumab) drug interactions
There are 176 drug interactions with Taltz (ixekizumab)
More about Taltz (ixekizumab)
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Interactions
- Pricing & Coupons
- 146 Reviews
- Drug class: interleukin inhibitors
- FDA Approval History
Related treatment guides
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|